EMT-Mediated Acquired EGFR-TKI Resistance in NSCLC: Mechanisms and Strategies

Acquired resistance inevitably limits the curative effects of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), which represent the classical paradigm of molecular-targeted therapies in non-small-cell lung cancer (NSCLC). How to break such a bottleneck becomes a pressing probl...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xuan, Chen, Lijie, Liu, Ling, Niu, Xing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798878/
https://www.ncbi.nlm.nih.gov/pubmed/31681582
http://dx.doi.org/10.3389/fonc.2019.01044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798878/
https://www.ncbi.nlm.nih.gov/pubmed/31681582
http://dx.doi.org/10.3389/fonc.2019.01044

Ejemplares similares